Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Beaumont

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Journal of the American Chemical Society|February 24, 2017
Efficient Liver Targeting by Polyvalent Display of a Compact Ligand for the Asialoglycoprotein ReceptorCarlos A Sanhueza, Michael M Baksh, Benjamin Thuma, et al.
Journal of Medicinal Chemistry|September 18, 2024
Structure-Based Optimization of a Series of Covalent, Cell Active Bfl-1 InhibitorsSimon C C Lucas, J Henry Blackwell, Ulf Börjesson, et al.
Journal of Medicinal Chemistry|October 19, 2017
Discovery of Potent and Orally Bioavailable Macrocyclic Peptide-Peptoid Hybrid CXCR7 ModulatorsMarkus Boehm, Kevin Beaumont, Rhys Jones, et al.
Angewandte Chemie (International Ed. in English)|October 27, 2017
Liver-Targeted Small-Molecule Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9 SynthesisKim F McClure, David W Piotrowski, Donna Petersen, et al.
Journal of Medicinal Chemistry|December 6, 2024
Structure-Based Discovery of a Series of Covalent, Orally Bioavailable, and Selective BFL1 InhibitorsAdeline Palisse, Tony Cheung, Aileen Blokhuis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2025
Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing CancersJason J Zoeller, Ravinder Tammali, Roger B Dodd, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Journal of the American Chemical Society|February 24, 2017
Efficient Liver Targeting by Polyvalent Display of a Compact Ligand for the Asialoglycoprotein ReceptorCarlos A Sanhueza, Michael M Baksh, Benjamin Thuma, et al.
Journal of Medicinal Chemistry|September 18, 2024
Structure-Based Optimization of a Series of Covalent, Cell Active Bfl-1 InhibitorsSimon C C Lucas, J Henry Blackwell, Ulf Börjesson, et al.
Journal of Medicinal Chemistry|October 19, 2017
Discovery of Potent and Orally Bioavailable Macrocyclic Peptide-Peptoid Hybrid CXCR7 ModulatorsMarkus Boehm, Kevin Beaumont, Rhys Jones, et al.
Angewandte Chemie (International Ed. in English)|October 27, 2017
Liver-Targeted Small-Molecule Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9 SynthesisKim F McClure, David W Piotrowski, Donna Petersen, et al.
Journal of Medicinal Chemistry|December 6, 2024
Structure-Based Discovery of a Series of Covalent, Orally Bioavailable, and Selective BFL1 InhibitorsAdeline Palisse, Tony Cheung, Aileen Blokhuis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2025
Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing CancersJason J Zoeller, Ravinder Tammali, Roger B Dodd, et al.
Pageof 5